UNSPSC 51201649: Human papilloma virus vaccine

This clasification denotes vaccines or candidate vaccines used to prevent or treat a genus of the family paramyxoviridae (subfamily paramyxovirinae) where the virions of most members have hemagglutinin but not neuraminidase activity. All members produce both cytoplasmic and intranuclear inclusion bodies. Human papilloma virus vaccine bears US NLM identifiers UMLS ID C1512511 and NCI Concept Code C1951.

UNSPSC 51201649 Human papilloma virus vaccine is a Commodity code that state and local health departments use to procure HPV immunization products for public health programs. The recent opportunities block shows minimal HPV-specific activity; the single posted solicitation—a Mississippi State Department of Health notice—concerns Yellow Fever Vaccine procurement, indicating a mismatch between the code's nominal scope and the work actually being tagged under it in current state and local opportunities. State health departments, county and municipal health offices, and school districts typically buy vaccines under this and related codes to support immunization mandates, school health clinics, and public disease-prevention initiatives. The structure of vaccine procurement varies—states may issue sole-source notices (as in the Mississippi case), competitive RFPs for ongoing supply contracts, or standing-order arrangements through cooperative purchasing vehicles and group purchasing organizations.

The recent opportunity signals limited current market visibility under the HPV vaccine code specifically. The Mississippi State Department of Health posted a sole-source notice for Yellow Fever Vaccine on July 13, 2026, with objections due August 3, 2026; the department identified Sanofi Pasteur, Inc. as the single proposed source, though the notice invites written objections demonstrating alternative suppliers exist. The notice does not disclose quantity, contract term, or estimated value. Absence of HPV vaccine–specific solicitations in the recent block suggests either that procurement under this code occurs through standing contracts, cooperative vehicles, or state group purchasing programs not individually posted, or that the code sees limited discrete buying activity in the current period. Firms pursuing HPV vaccine supply should monitor state immunization program notices and school district health procurement channels, particularly in states with active HPV vaccination mandates.